Description
We are a manufacturer of high-precision oligonucleotides for IVD and gene therapy applications.
Type of Drugs Manufactured:
Small Molecule;Biologics;Cell & Gene Therapy
CDMO Services:
Drug Substance Manufacturing (API);Research & Development
No. of Manufacturing Facilities:
3-5
High Potent Products capabilities:
OEB 3
Facilities Locations:
Middle East;North America;China
Regulatory Approvals for facilities:
ISO
Manufacturing Technologies:
Cartridges;Liquids;Lyophilized amps/vials;Semi-solids;Solids;Sterile Vials
Current Capacity:
Scalability: Capacity to synthesize 10,000+ oligos/month, from research-grade to GMP-level.
Customized Solutions: Specialized in custom modifications (e.g., probes, LNA, qPCR primers) for IVD and gene editing workflows.
We also have scientific team to provide services of design, synthesis, and validation for all kinds of oligos. We manufactured different tool enzymes and NGS related products.
Related Listings

External Manufacturing Leaders Basel 2026
Exclusive event for senior external manufacturing leaders. Basel

CDMO Live Americas . October 20-21, Boston 2026
Experience the future of external manufacturing at CDMO Live, Rotterdam.
19-21st Oct 2026











